# OxSyns Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxsyns-biotech

- Industry: Materials
- Headquarters: Shenzhen, China
- Website: www.oxsyns.com
- Latest round: Angel (Apr 29, 2024)
- Investors on record: 4

## About

Based in Shenzhen, China and founded in 2022, Shenzhen OxSyns Biotech Co., Ltd., dba Oxsyns Biotech, is an innovator in the field of bio-electrochemical technologies. The company's founding team are all from Oxford University and have won first place in the Oxford University Entrepreneurship Competition. The company has won the first prize of China Nanotechnology Competition, the Ministry of Education Chunhui Cup Winner Award and other honors, and has R&D centers in Shenzhen and Beijing, and a pilot experiment platform in Shanghai. In January 2026, OxSyns Biotech closed a venture funding from ZJVC Venture Capital and Fong Capital Partners.

The company focus on the development and production of high-value small molecules with precision and consistency through innovative systems for continuous, multi-enzyme cascade production. The coenzyme products are tailored for versatile applications, such as supplements, IVD reagents, and cosmetics, where they support biochemical reactions, enable accurate detection, and promote skin health, respectively. 

The company generates revenue by providing bio-electrochemical solutions, including the synthesis of high-value small molecules and the development of coenzyme products for various applications.

## Funding rounds

- Angel, Apr 29, 2024 — CDH Investments, China Prosperity Capital, Innoangel Fund, Tianze Capital Management

## Investors

- CDH Investments (https://capitalatlas.ai/funds/cdh-investments) — Angel
- China Prosperity Capital (https://capitalatlas.ai/funds/china-prosperity-capital) — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel
- Tianze Capital Management (https://capitalatlas.ai/funds/tianze-capital-management) — Angel